The Consumer Reports Guide to Trials

Statistical Significance vs. Clinical Importance. MCID Threshold for UA/NSTEMI ACS “ In ACS, a relative reduction of 15% in recurrent clinical events has recently been considered clinically important (GUSTO I); this level is far below the perceived threshold that drove the sample size calculations for clinical trials just a decade ago. As we ... ................
................